U.S. markets closed
  • S&P 500

    3,971.27
    -6.26 (-0.16%)
     
  • Dow 30

    32,394.25
    -37.83 (-0.12%)
     
  • Nasdaq

    11,716.08
    -52.76 (-0.45%)
     
  • Russell 2000

    1,752.63
    -1.04 (-0.06%)
     
  • Crude Oil

    73.71
    +0.51 (+0.70%)
     
  • Gold

    1,975.40
    +1.90 (+0.10%)
     
  • Silver

    23.50
    +0.08 (+0.36%)
     
  • EUR/USD

    1.0851
    +0.0047 (+0.4340%)
     
  • 10-Yr Bond

    3.5640
    +0.0360 (+1.02%)
     
  • Vix

    19.97
    -0.63 (-3.06%)
     
  • GBP/USD

    1.2336
    +0.0055 (+0.4441%)
     
  • USD/JPY

    130.7760
    -0.7790 (-0.5921%)
     
  • BTC-USD

    27,197.41
    +73.43 (+0.27%)
     
  • CMC Crypto 200

    598.52
    +355.84 (+146.63%)
     
  • FTSE 100

    7,484.25
    +12.48 (+0.17%)
     
  • Nikkei 225

    27,518.25
    +41.38 (+0.15%)
     

AbbVie Posts an Earnings Beat but Forecast Misses as Competition Intensifies

AbbVie Posts an Earnings Beat but Forecast Misses as Competition Intensifies

AbbVie reported quarterly earnings that beat analysts’ estimates but revenue below consensus as sales for many of its drugs declined from the prior year. The company’s full-year earnings forecast also missed estimates. AbbVie (ticker: ABBV) reported adjusted fourth-quarter earnings of $3.60 a share on revenue of $15.12 billion, compared to year-earlier profit of $3.08 a share on sales of $14.89 billion.